Poland
· Delayed Price · Currency is PLN Nestmedic Statistics
Total Valuation
Nestmedic has a market cap or net worth of PLN 24.52 million. The enterprise value is 25.31 million.
| Market Cap | 24.52M |
| Enterprise Value | 25.31M |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nestmedic has 36.59 million shares outstanding.
| Current Share Class | 36.59M |
| Shares Outstanding | 36.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.17% |
| Owned by Institutions (%) | 0.39% |
| Float | 13.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.02 |
| PB Ratio | 3.57 |
| P/TBV Ratio | 36.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.40 |
| EV / Sales | 23.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.05 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.40 |
Financial Efficiency
Return on equity (ROE) is -86.09% and return on invested capital (ROIC) is -28.85%.
| Return on Equity (ROE) | -86.09% |
| Return on Assets (ROA) | -20.63% |
| Return on Invested Capital (ROIC) | -28.85% |
| Return on Capital Employed (ROCE) | -62.37% |
| Revenue Per Employee | 354,955 |
| Profits Per Employee | -1.56M |
| Employee Count | 4 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.10 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.22% in the last 52 weeks. The beta is 0.10, so Nestmedic's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -8.22% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 60.79 |
| Average Volume (20 Days) | 174,468 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nestmedic had revenue of PLN 1.06 million and -4.69 million in losses.
| Revenue | 1.06M |
| Gross Profit | 691,811 |
| Operating Income | -4.39M |
| Pretax Income | -4.69M |
| Net Income | -4.69M |
| EBITDA | -4.24M |
| EBIT | -4.39M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 2.78 million in cash and 3.57 million in debt, giving a net cash position of -796,270 or -0.02 per share.
| Cash & Cash Equivalents | 2.78M |
| Total Debt | 3.57M |
| Net Cash | -796,270 |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 6.86M |
| Book Value Per Share | n/a |
| Working Capital | 364,330 |
Cash Flow
| Operating Cash Flow | -4.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 64.97% |
| Operating Margin | -412.44% |
| Pretax Margin | -440.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nestmedic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -19.13% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |